Cargando…

Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells

BACKGROUND: Ougan (Citrus reticulata cv. Suavissima) flavedo extract (OFE) exhibited potential anti-tumor effects with unclear underlying mechanisms. This study aims to evaluate the potential anti-metastatic activities of OFE on human ovarian cancer cells, and investigate its inhibitory effect on ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Linlin, Jia, Sheng, Fu, Yingying, Zhou, Tianyi, Cao, Ji, He, Qiaojun, Yang, Bo, Li, Xian, Sun, Chongde, Su, Dan, Zhu, Hong, Chen, Kunsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486131/
https://www.ncbi.nlm.nih.gov/pubmed/26131016
http://dx.doi.org/10.1186/s13020-015-0042-0
_version_ 1782378859000233984
author Chang, Linlin
Jia, Sheng
Fu, Yingying
Zhou, Tianyi
Cao, Ji
He, Qiaojun
Yang, Bo
Li, Xian
Sun, Chongde
Su, Dan
Zhu, Hong
Chen, Kunsong
author_facet Chang, Linlin
Jia, Sheng
Fu, Yingying
Zhou, Tianyi
Cao, Ji
He, Qiaojun
Yang, Bo
Li, Xian
Sun, Chongde
Su, Dan
Zhu, Hong
Chen, Kunsong
author_sort Chang, Linlin
collection PubMed
description BACKGROUND: Ougan (Citrus reticulata cv. Suavissima) flavedo extract (OFE) exhibited potential anti-tumor effects with unclear underlying mechanisms. This study aims to evaluate the potential anti-metastatic activities of OFE on human ovarian cancer cells, and investigate its inhibitory effect on epithelial-to-mesenchymal transition (EMT). METHODS: Ougan fruits were harvested. Flavedo tissues were separated and made into freeze-dried powder. Then OFE were extracted from the powder. The components of OFE were identified by the high performance liquid chromatography system with a detection wavelength of 280 nm for flavanones and 330 nm for polymethoxylated flavones. Cell viability was assessed by Sulforhodamine B assay. The effects on cancer cell migration and motility were evaluated by wound-healing and transwell assays. The mechanisms of action were investigated by examining the modulation by OFE on EMT-related signaling pathways at the concentrations of 4 μg/mL and 20 μg/mL, using qRT-PCR and western blot analyses. RESULTS: Non-cytotoxic concentrations of OFE significantly suppressed the cellular migration (4 μg/mL, P = 0.005 vs. control group; 20 μg/mL, P = 0.003 vs. control group) and motility (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL, P < 0.001 vs. control group) of SKOV3 cells, and inhibited transforming growth factor-β1 (TGF-β1)-induced E-cadherin loss (4 μg/mL, P = 0.002 vs. control group; 20 μg/mL, P = 0.001 vs. control group) and mesenchymal marker upregulation, e.g., N-cadherin (4 μg/mL, P = 0.027 vs. control group; 20 μg/mL, P = 0.013 vs. control group), vimentin (4 μg/mL, P = 0.036 vs. control group; 20 μg/mL, P = 0.015 vs. control group) and fibronectin (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL, P < 0.001 vs. control group). CONCLUSIONS: The anti-metastatic ability of OFE inhibited EMT by interfering with the canonical TGF-β1-SMAD-Snail/Slug axis.
format Online
Article
Text
id pubmed-4486131
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44861312015-07-01 Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells Chang, Linlin Jia, Sheng Fu, Yingying Zhou, Tianyi Cao, Ji He, Qiaojun Yang, Bo Li, Xian Sun, Chongde Su, Dan Zhu, Hong Chen, Kunsong Chin Med Research BACKGROUND: Ougan (Citrus reticulata cv. Suavissima) flavedo extract (OFE) exhibited potential anti-tumor effects with unclear underlying mechanisms. This study aims to evaluate the potential anti-metastatic activities of OFE on human ovarian cancer cells, and investigate its inhibitory effect on epithelial-to-mesenchymal transition (EMT). METHODS: Ougan fruits were harvested. Flavedo tissues were separated and made into freeze-dried powder. Then OFE were extracted from the powder. The components of OFE were identified by the high performance liquid chromatography system with a detection wavelength of 280 nm for flavanones and 330 nm for polymethoxylated flavones. Cell viability was assessed by Sulforhodamine B assay. The effects on cancer cell migration and motility were evaluated by wound-healing and transwell assays. The mechanisms of action were investigated by examining the modulation by OFE on EMT-related signaling pathways at the concentrations of 4 μg/mL and 20 μg/mL, using qRT-PCR and western blot analyses. RESULTS: Non-cytotoxic concentrations of OFE significantly suppressed the cellular migration (4 μg/mL, P = 0.005 vs. control group; 20 μg/mL, P = 0.003 vs. control group) and motility (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL, P < 0.001 vs. control group) of SKOV3 cells, and inhibited transforming growth factor-β1 (TGF-β1)-induced E-cadherin loss (4 μg/mL, P = 0.002 vs. control group; 20 μg/mL, P = 0.001 vs. control group) and mesenchymal marker upregulation, e.g., N-cadherin (4 μg/mL, P = 0.027 vs. control group; 20 μg/mL, P = 0.013 vs. control group), vimentin (4 μg/mL, P = 0.036 vs. control group; 20 μg/mL, P = 0.015 vs. control group) and fibronectin (4 μg/mL, P < 0.001 vs. control group; 20 μg/mL, P < 0.001 vs. control group). CONCLUSIONS: The anti-metastatic ability of OFE inhibited EMT by interfering with the canonical TGF-β1-SMAD-Snail/Slug axis. BioMed Central 2015-06-27 /pmc/articles/PMC4486131/ /pubmed/26131016 http://dx.doi.org/10.1186/s13020-015-0042-0 Text en © Chang et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chang, Linlin
Jia, Sheng
Fu, Yingying
Zhou, Tianyi
Cao, Ji
He, Qiaojun
Yang, Bo
Li, Xian
Sun, Chongde
Su, Dan
Zhu, Hong
Chen, Kunsong
Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title_full Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title_fullStr Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title_full_unstemmed Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title_short Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
title_sort ougan (citrus reticulata cv. suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in skov3 cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486131/
https://www.ncbi.nlm.nih.gov/pubmed/26131016
http://dx.doi.org/10.1186/s13020-015-0042-0
work_keys_str_mv AT changlinlin ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT jiasheng ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT fuyingying ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT zhoutianyi ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT caoji ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT heqiaojun ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT yangbo ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT lixian ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT sunchongde ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT sudan ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT zhuhong ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells
AT chenkunsong ougancitrusreticulatacvsuavissimaflavedoextractsuppressescancermotilitybyinterferingwithepithelialtomesenchymaltransitioninskov3cells